دورية
Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study
| العنوان: | Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study |
|---|---|
| المؤلفون: | Scully, Marie, de la Rubia, Javier, Pavenski, Katerina, Metjian, Ara, Knöbl, Paul, Peyvandi, Flora, Cataland, Spero, Coppo, Paul, Kremer Hovinga, Johanna A., Minkue Mi Edou, Jessica, De Passos Sousa, Rui, Callewaert, Filip, Gunawardena, Sriya, Lin, Julie |
| المصدر: | Journal of Thrombosis and Haemostasis; December 2022, Vol. 20 Issue: 12 p2810-2822, 13p |
| مستخلص: | Caplacizumab demonstrated efficacy and safety in patients with immune‐mediated thrombotic thrombocytopenic purpura (iTTP) in the phase 3 HERCULES trial. However, data on long‐term outcomes following caplacizumab treatment are limited. |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder | تدمد: | 15387933 15387836 |
|---|---|
| DOI: | 10.1111/jth.15892 |